Old Web
English
Sign In
Acemap
>
authorDetail
>
Linda E. Coate
Linda E. Coate
University Health Network
Medicine
Confidence interval
Lung cancer
Surgery
Proportional hazards model
4
Papers
93
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
P34.01 Utility of Assessment of the EGFR Resistance Genotype using Cell-Free DNA and CTCs from Liquid Biopsies
2021
Journal of Thoracic Oncology
Martin P. Barr
Anne-Marie Baird
S.G. Gray
B. Hayes
Petra Martin
S. Halliday
Cathal OBrien
Grzegorz Korpanty
Linda E. Coate
Sinead Cuffe
S.P. Finn
Show All
Source
Cite
Save
Citations (0)
P76.49 The Impact of Baseline Systemic Inflammatory Status Parameters in Patients Treated with EGFR-Tyrosine Kinase Inhibitors
2021
Journal of Thoracic Oncology
Petra Martin
Martin P. Barr
Anne-Marie Baird
S. Halliday
B. Hayes
Sinead Cuffe
Linda E. Coate
S.G. Gray
S.P. Finn
Show All
Source
Cite
Save
Citations (0)
Neoadjuvant chemoradiation and surgery improves survival outcomes compared with definitive chemoradiation in the treatment of stage IIIA N2 non-small-cell lung cancer
2015
European Journal of Cardio-Thoracic Surgery
Gail Darling
Fei Li
Demetris Patsios
Christine Massey
Adam G. Wallis
Linda E. Coate
Shaf Keshavjee
A. Pierre
Marc de Perrot
Kazuhiro Yasufuku
Marcelo Cypel
Thomas K. Waddell
Show All
Source
Cite
Save
Citations (28)
Elderly Patients with Advanced NSCLC in Phase III Clinical Trials: Are the Elderly Excluded from Practice-Changing Trials in Advanced NSCLC?
2013
Journal of Thoracic Oncology
Adrian Sacher
Lisa W. Le
Natasha B. Leighl
Linda E. Coate
Show All
Source
Cite
Save
Citations (65)
1